iopromide has been researched along with Carcinoma, Ductal, Breast in 1 studies
iopromide: structure given in first source
iopromide : A dicarboxylic acid diamide that consists of N-methylisophthalamide bearing three iodo substituents at positions 2, 4 and 6, a methoxyacetyl substituent at position 5 and two 2,3-dihydroxypropyl groups attached to the amide nitrogens. A water soluble x-ray contrast agent for intravascular administration.
Carcinoma, Ductal, Breast: An invasive (infiltrating) CARCINOMA of the mammary ductal system (MAMMARY GLANDS) in the human BREAST.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Łuczyńska, E | 1 |
| Heinze-Paluchowska, S | 1 |
| Hendrick, E | 1 |
| Dyczek, S | 1 |
| Ryś, J | 1 |
| Herman, K | 1 |
| Blecharz, P | 1 |
| Jakubowicz, J | 1 |
1 trial available for iopromide and Carcinoma, Ductal, Breast
| Article | Year |
|---|---|
Comparison between breast MRI and contrast-enhanced spectral mammography.
Topics: Breast Diseases; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Intraductal, Noninfiltratin | 2015 |